Skip to main content

Coronavirus: Stem Cells Offer a Ray of Hope in Battle Against Covid-19

Image
By

Coronavirus: Stem cells offer a ray of hope in battle against covid-19


A new candidate has emerged in the race to find a cure for covid-19—stem-cells.
Stem Cells Offer a Ray of Hope in Battle Against Covid-19
The therapeutic approach involves intravenous injection of mesenchymal stem-cells (MSC) from a human placenta into a covid-19 patient to boost the body’s immune response against the infection.
Key scientific groups worldwide, including those in China and the US, have been working to test the treatment. Some have reported promising results.
An Israeli pharmaceutical company, Pluristem Therapeutics, has tested it in seven critical hospitalized patients and found positive results. The company is now seeking approval to begin clinical trials.
The US Food and Drug Administration (FDA) has already approved clinical trials to study covid-19 patients who have been administered MSC derived from the placenta to prevent inflammation of lungs.
One 24-patient trial is set to begin soon in the US, the worst affected country with more than 780,000 coronavirus cases. The FDA has also shared a clinical protocol.
Indian scientists, too, are examining the effectiveness of the treatment and looking at the preliminary results from the trials abroad.
“There is indeed potential. However, unless we do some trials, we cannot how effective it is. It may be successful in some cases and not in others, but we have to see. As there is no established treatment for covid-19 yet, this approach may be worth trying," said senior cell-biologist Dr Mohan Wani, from the National Centre for Cell Science (NCCS) in Pune.
Stem-cells have been successful in treating degenerative diseases, especially Alzheimer’s, as well as Type-1 diabetes.
“The advantage that stem-cells have is that they have strong anti-inflammatory and immunomodulatory properties, which can help strengthen our immune system. This is important in case of covid-19, where they could reduce inflammation of the lungs, which are the most affected," said Wani.
Stem-cell therapy could help build up regenerative cells in the lungs, which could protect the epithelial cells of the lungs, prevent lung damage and help patients recover, according to some scientists.
However, as the therapeutic approach is in its preliminary stages, it could be months before it is given approval for treatment.
There are also tight regulations in place to ensure that this approach does not pose any risk, because of the relative newness of stem-cell treatment.

Comments

Post a Comment

Popular posts from this blog

Lab-Grown Blood Stem Cells Produced at Last

By
After 20 years of trying, scientists have transformed mature cells into primordial blood cells that regenerate themselves and the components of blood. The work, described today in Nature, offers hope to people with leukaemia and other blood disorders who need bone-marrow transplants but can’t find a compatible donor. If the findings translate into the clinic, these patients could receive lab-grown versions of their own healthy cells. One team, led by stem-cell biologist George Daley of Boston Children’s Hospital in Massachusetts, created human cells that act like blood stem cells, although they are not identical to those found in nature. A second team, led by stem-cell biologist Shahin Rafii of Weill Cornell Medical College in New York City, turned mature cells from mice into fully fledged blood stem cells. “For many years, people have figured out parts of this recipe, but they’ve never quite gotten there,” says Mick Bhatia, a stem-cell researcher at McMaster University i...
Post a Comment
Read more

Mesentery: New organ discovered inside human body by scientists

By
A new organ has been discovered hiding in plain sight inside the  human body . Known as the mesentery, it was previously thought to be just a few fragmented structures in the digestive system. But scientists have realised it is in fact one, continuous organ.  Although its function is still unclear, the discovery opens up “a whole new area of science,” according to J Calvin Coffey, a researcher at the  University Hospital Limerick  who first discovered it.  "When we approach it like every other organ… we can categorise abdominal disease in terms of this organ," he said.   “Now we have established anatomy and the structure. The next step is the function. If you understand the function you can identify abnormal function, and then you have disease.  “Put them all together and you have the field of mesenteric science.” The research has been published in  The Lancet   medical journa...
Post a Comment
Read more

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

By
Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...
Post a Comment
Read more